OPNT
Opiant Pharmaceuticals, Inc.
Set alert
20.65 0.00 0.00%
20.56 Day range 20.94
52-week range unavailable
- Open
- 20.88
- Prev close
- 20.65
- Mkt cap
- 108.80M
- Vol
- 562.78K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.56
- High
- 20.94
- Forward P/E
- -4.88
- Beta
- 0.83
- Short ratio
- 0.56
- Inst. own
- 42.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 21, 2023
- 50-d avg
- 20.50
- 200-d avg
- 14.79
- 1y target
- 21.00
Ownership
Held by insiders 7.63%
Held by institutions 42.00%
Float held by institutions 45.47%
Institutions 46
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Western Standard, LLC | 15.02% | 424,080 | 8.76M | Dec 30, 2022 |
| Apis Capital Advisors, LLC | 7.58% | 214,000 | 4.42M | Dec 30, 2022 |
| Morgan Stanley | 7.00% | 197,652 | 4.08M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 6.76% | 190,773 | 3.94M | Dec 30, 2022 |
| Renaissance Technologies, LLC | 5.19% | 146,415 | 3.02M | Dec 30, 2022 |
| Wells Fargo & Company | 4.85% | 136,814 | 2.83M | Dec 30, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 4.26% | 120,263 | 2.48M | Sep 29, 2022 |
| Vanguard Extended Market Index Fund | 2.21% | 62,250 | 1.29M | Sep 29, 2022 |
| IndexIQ Tr-IQ Merger Arbitrage ETF | 2.19% | 61,912 | 1.28M | Dec 30, 2022 |
| DFA U.S. Targeted Value Portfolio | 1.05% | 29,507 | 609.32K | Oct 30, 2022 |
| Fidelity Extended Market Index Fund | 0.99% | 27,806 | 574.19K | Nov 29, 2022 |
| DFA U.S. Small Cap Series | 0.65% | 18,273 | 377.34K | Oct 30, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COLLARD CRAIG A | Director | Stock Award(Grant) | Jun 13, 2022 | 55,822 |
| CRYSTAL ROGER | Chief Executive Officer | Sale | Jan 26, 2023 | 75,339 |
| DALY RICHARD J | Director | Stock Award(Grant) | Jun 13, 2022 | 7,800 |
| ELLISON MARK JASON HEATH | Officer | Sale | Jan 26, 2023 | 18,751 |
| GORMAN BRIAN | General Counsel | Sale | Jan 26, 2023 | 31,990 |
| O'TOOLE DAVID D | Chief Financial Officer | Sale | Jan 26, 2023 | 34,248 |